Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
delpazolid (LCB01-0371)
i
Other names:
LCB01-0371, LCB-01371, RMX 2001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
HaiHe Biopharma, LigaChem Biosci
Drug class:
Protein synthesis inhibitor
Related drugs:
‹
MT-5111 (4)
omacetaxine mepesuccinate (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
Imtox19/Imtox22 (0)
MT-3724 (0)
OXS-1550 (0)
SVC112 (0)
oportuzumab monatox (0)
minocycline (0)
RSO-021 (0)
MT-5111 (4)
omacetaxine mepesuccinate (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
Imtox19/Imtox22 (0)
MT-3724 (0)
OXS-1550 (0)
SVC112 (0)
oportuzumab monatox (0)
minocycline (0)
RSO-021 (0)
›
Associations
(1)
News
Trials
Filter by
Latest
4ms
Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex (clinicaltrials.gov)
P2, N=20, Recruiting, LigaChem Biosciences, Inc. | Active, not recruiting --> Recruiting
4 months ago
Enrollment open
|
delpazolid (LCB01-0371)
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login